Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir monotherapy versus lamivudine + adefovir combination in HBeAg-positive chronic hepatitis B with high viral load
ChiCTR-ONRC-12002315Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir, lamivudine and adefovir dipivoxil in Chronic Hepatitis B (CHB) (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Virological response. Started Sep 2011; status: completed.
02
Drugs
entecavirlamivudineadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-ONRC-12002315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002315.